AdaptHealth Corp.

  • Market Cap: Small Cap
  • Industry: Finance
  • ISIN: US00653Q1022
USD
9.38
-0.05 (-0.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About AdaptHealth Corp. stock-summary
stock-summary
AdaptHealth Corp.
Finance
Adapthealth Corp. is a provider of home healthcare equipment, medical supplies to the home and related services in the United States. The Company is focused on primarily providing sleep therapy equipment, supplies and related services to individuals suffering from obstructive sleep apnea (OSA), home medical equipment (HME) to patients discharged from acute care and other facilities. The Company offers oxygen and related chronic therapy services in the home, and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy and nutritional supply needs. The company is also partners’ with diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. The Company services beneficiaries of Medicare, Medicaid and commercial insurance payors and services over approximately 1.6 million patients annually.
Company Coordinates stock-summary
Company Details
220 W Germantown Pike Ste 250 , PLYMOUTH MEETING PA : 19462
stock-summary
Tel: 1 610 6306357
stock-summary
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 73 Schemes (47.97%)

Foreign Institutions

Held by 103 Foreign Institutions (5.35%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Richard Barasch
Independent Chairman of the Board
Mr. Joshua Parnes
President, Director
Mr. Luke Mcgee
Chief Executive Officer, Director
Mr. Terence Connors
Independent Director
Mr. Alan Quasha
Independent Director
Dr. Susan Weaver
Independent Director
Mr. David Williams
Independent Director
Mr. Dale Wolf
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
800 Million
(Quarterly Results - Jun 2025)
Net Profit:
15 Million
stock-summary
Industry

Finance

stock-summary
Market cap

USD 1,275 Million (Small Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

5.50%

stock-summary
Price to Book

0.80